Watch this video from EFPIA and Vaccines Europe on how to shorten the vaccine development timeline to respond to a global pandemic
We strive to provide hope to people with cancer.
MSD operates one of the world's largest and fastest growing clinical research programs in the field of immuno-oncology. In Belgium, we are currently conducting 34 clinical trials (04/2019) in various types of cancer.
For more than 100 years, we have been researching and developing innovative vaccines to help prevent certain diseases in children, adolescents and adults.
MSD is one of the world's leading research-based biopharmaceutical companies. For more than 125 years, we have been developing and providing medicines and vaccines that can improve the health of people and animals and enable them to live better lives.
Based in Brussels, Heist-op-den-Berg and Windhof (Grand Duchy of Luxembourg).
MSD Belgium & Luxembourg employs about 1220 people spread over 4 different sites; 2 in Brussels, 1 in Flanders (Heist-op-den-Berg) and 1 in Grand Duchy Luxembourg (Windhof).
In order to comprehensively address health issues, we seek collaborative partnerships with healthcare decision-makers. We work together to develop innovative solutions that contribute to improving patients' health in Belgium.
The MSD Corporate Volunteering Program is an expression of our corporate responsibility. With this program, we give employees time to get involved in social projects to support other people – voluntarily and compensated as paid leave.
Dedicated, responsible people from all over the world work at MSD in Belgium & Luxembourg.
In our Brussels site and the production site in Heist-op-den-Berg, we train young people and offer exciting national and international positions in a wide range of fields.